BAX
Baxter International Inc.
BAX lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve.
BAX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Unavailable | |
| Strong |
BAX's balance sheet is currently strong, and its revenue is stable, but its profitability is under pressure. There isn't enough data to rate its cash flow.
BAX PE Valuation
BAX has no meaningful PE right now: it lost money over the past year.
BAX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAX, with profitability improving.
BAX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.06 | — |
| Q3 2026 | -$1.43 | -$0.77 |
| Q2 2026 | -$2.09 | -$1.79 |
| Q1 2026 | -$2.15 | -$1.05 |
| Q4 2025 | -$1.87 | -$0.59 |
| Q3 2025 | -$0.66 | -430% |
| Q2 2025 | -$0.30 | -106% |
| Q1 2025 | -$1.10 | -121% |
| Q4 2024 | -$1.28 | -125% |
BAX is still losing money, but far less than before: $1.43 per share over the past year, against $5.66 at its worst in mid-2023.
BAX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3B | +5% |
| Q2 2026 | $3B | +5.3% |
| Q1 2026 | $2.7B | +2.9% |
| Q4 2025 | $3B | +8% |
| Q3 2025 | $2.8B | +5% |
| Q2 2025 | $2.8B | -26% |
| Q1 2025 | $2.6B | -27% |
| Q4 2024 | $2.8B | -29% |
BAX's revenue has grown year over year for five quarters in a row: $3B last quarter, up 5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.6% | +1.5 points |
| Q2 2026 | 7.3% | +0.5 points |
| Q1 2026 | 2.4% | +0.2 points |
| Q4 2025 | -25% | -8.7 points |
| Q3 2025 | 6.1% | +0.3 points |
| Q2 2025 | 6.8% | +12 points |
| Q1 2025 | 2.2% | -3 points |
| Q4 2024 | -16% | -24 points |
BAX's operating margin was 7.6% last quarter, up 1.5 points from the same quarter a year ago.
BAX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $558M | +135% |
| Q2 2026 | $285M | +31% |
| Q1 2026 | $213M | +$406M |
| Q3 2025 | $237M | -6.3% |
| Q2 2025 | $217M | +89% |
| Q1 2025 | -$193M | -218% |
| Q3 2024 | $253M | +32% |
| Q2 2024 | $115M | -41% |
BAX generated $1.3B in free cash flow over the past year, about three times what it generated the year before.
BAX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +2M shares |
| 1 year | +1.2% | +6M shares |
| 3 years | +2.2% | +11M shares |
| 5 years | +2.8% | +14M shares |
| Available history | +0.2% | +1M shares |
BAX has 520M diluted shares, up 1.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q4 2022 | — |
| Q3 2022 | $32M |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | $35M |
| Q2 2021 | $312M |
BAX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.5x | Net Cash |
| Q2 2026 | -1.9x | Net Cash |
| Q1 2026 | -1.8x | Net Cash |
| Q4 2025 | 11.2x | High |
| Q3 2025 | -1.0x | Net Cash |
| Q2 2025 | -2.0x | Net Cash |
| Q1 2025 | -3.3x | Net Cash |
| Q4 2024 | 16.0x | High |
BAX has more cash than debt.
BAX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.5 | Neutral |
| Stochastic | 40.5 | Neutral |
BAX's weekly RSI is 59 (neutral) and its Stochastic is 40 (neutral).
BAX PE vs Healthcare Sector
| Metric | BAX | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
BAX has no meaningful PE right now: it lost money over the past year.
BAX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $24.5 | 4.9% above |
| 20 week MA | $24.6 | 4.6% above |
| 50 week MA | $21.3 | 21% above |
| 100 week MA | $24.5 | 5.1% above |
| 200 week MA | $31.7 | 19% below |
BAX has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 19% below its 200-week average.
BAX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $84.1 | $79.6 | -5.3% |
| 2021 | $79.6 | $85.6 | +7.5% |
| 2022 | $85.6 | $50.2 | -41% |
| 2023 | $50.2 | $38.7 | -23% |
| 2024 | $38.7 | $29.2 | -24% |
| 2025 | $29.2 | $19.4 | -34% |
| 2026 YTD | $19.4 | $25.7 | +33% |
BAX has finished four years in a row lower, and it's up 33% so far in 2026.